Genomics BioSci & Tech. Co.,Ltd. (TPE:4195)
Taiwan · Delayed Price · Currency is TWD 13.60
-0.60 (-4.23%)
At close: Sep 11, 2026
Genomics BioSci & Tech. Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,088 | 1,862 | 1,391 | 1,507 | 1,257 | 1,126 | |
Market Cap Growth | -39.93% | 33.85% | -7.69% | 19.84% | 11.67% | 0.78% |
Enterprise Value | 1,531 | 2,385 | 1,622 | 1,416 | 1,233 | 1,074 |
Last Close Price | 13.60 | 25.70 | 19.20 | 20.80 | 19.35 | 18.37 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 17.56 | 60.09 |
PS Ratio | 1.51 | 2.63 | 2.69 | 3.80 | 3.00 | 2.89 |
PB Ratio | 1.45 | 3.20 | 2.17 | 1.97 | 1.59 | 1.66 |
P/TBV Ratio | 1.66 | 3.70 | 2.56 | 1.97 | 1.60 | 1.66 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.13 | 3.37 | 3.13 | 3.57 | 2.94 | 2.75 |
EV/EBITDA Ratio | - | - | - | - | - | 1319.50 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.72 | 1.08 | 0.79 | 0.37 | 0.29 | 0.13 |
Debt / EBITDA Ratio | - | - | - | - | - | 18.95 |
Net Debt / Equity Ratio | 0.48 | 0.78 | 0.42 | 0.04 | -0.11 | -0.03 |
Net Debt / EBITDA Ratio | -5.94 | -21.97 | -3.15 | -0.62 | 16.29 | -25.75 |
Net Debt / FCF Ratio | -3.90 | -2.84 | -0.88 | -0.12 | 0.77 | 0.17 |
Asset Turnover | 0.51 | 0.51 | 0.42 | 0.35 | 0.43 | 0.39 |
Inventory Turnover | 2.44 | 2.26 | 2.92 | 4.75 | 7.47 | 12.45 |
Quick Ratio | 0.77 | 0.67 | 0.98 | 2.53 | 2.47 | 2.02 |
Current Ratio | 1.43 | 1.20 | 1.61 | 3.23 | 2.95 | 2.66 |
Return on Equity (ROE) | -8.33% | -11.06% | -33.47% | -21.62% | 9.75% | 1.52% |
Return on Assets (ROA) | -5.76% | -3.77% | -7.03% | -4.54% | -2.12% | -1.78% |
Return on Invested Capital (ROIC) | -11.99% | -8.64% | -16.44% | -10.94% | -4.89% | -5.17% |
Return on Capital Employed (ROCE) | -12.60% | -9.40% | -14.40% | -8.30% | -3.50% | -3.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -2.36% | -2.12% | -16.04% | -11.15% | 5.69% | 1.66% |
FCF Yield | -8.46% | -8.61% | -21.95% | -16.34% | -9.16% | -10.78% |
Dividend Yield | - | - | - | - | 0.51% | - |
Payout Ratio | - | - | - | - | 0.00% | 0.19% |
Buyback Yield / Dilution | -1.58% | - | -1.89% | -11.87% | -5.12% | -0.23% |
Total Shareholder Return | -1.58% | - | -1.89% | -11.87% | -4.62% | -0.23% |